Health
The Man Who Defied Alzheimer’s and Stumped Scientists
At 76 years old, Doug Whitney lives near Seattle and appears mentally sharp. Yet his story is far from ordinary — despite carrying a gene nearly certain to cause early-onset Alzheimer’s disease, he has shown no signs of cognitive decline. His situation baffled scientists at Washington University School of Medicine (WashU), who believe his resilience might hold clues to preventing Alzheimer’s. The Genetic Odds Were Against Him Whitney inherited a rare mutation in the PSEN2 gene — a genetic change known to virtually guarantee early-onset Alzheimer’s, often starting in the 50s or even younger. In his family, many carriers developed the disease and died before age 60 or in their early 50s. Whitney’s brother, for example, died at 55 after developing Alzheimer’s. Yet Whitney has reached his mid-70s with no symptoms. In fact, when he volunteered for a study of his family’s inherited Alzheimer’s risk, he believed he didn’t carry the mutation — only to learn he did. What Researchers Found — And What They Still Don’t Know Intrigued by Whitney’s resilience, the WashU team published findings in the journal Nature Medicine. They conducted genetic analyses and brain imaging — and made two standout discoveries: Whitney’s brain showed high levels of amyloid protein, which usually accumulates early in Alzheimer’s disease. Yet, in contrast, his brain showed virtually no buildup of tau protein, which is strongly linked to the onset of cognitive decline. According to senior author Randall J. Bateman, this combination — amyloid present but tau absent — points to what the team calls “remarkable resistance to tau pathology and neurodegeneration.” Moreover, they detected unusually high levels of “heat-shock” proteins in Whitney’s cerebrospinal fluid. These proteins help cells deal with stress — and in his case, might have helped block tau accumulation. Whitney, who served in the Navy, told Fox News Digital he often worked in engine rooms where temperatures climbed above 100 °F — a factor scientists think may have triggered those protective proteins in his brain. But the mechanism is still unknown. Scientists don’t yet know for sure whether the heat-shock proteins are what prevented tau buildup, or whether some other genetic or environmental factor is at work. (MORE NEWS: Everyday Medications May Reshape Your Gut for Years) Why This Case Matters Whitney’s case offers a unique window into Alzheimer’s resistance. Rather than simply studying those who develop the disease, scientists are increasingly focusing on those who don’t develop it despite high risk. If the protective factors can be understood, they may inform therapies that delay or prevent Alzheimer’s in others. As co-first author Jorge Llibre-Guerra put it: “If we are able to uncover the mechanism behind this resilience, we could try to replicate it with a targeted therapy designed to … benefit others.” In other words, Whitney may serve less as a patient and more as a model of what could be possible for many. What the Man Himself Thinks Whitney says he feels healthy and active. He and his wife often do crossword puzzles and sudoku to keep their minds sharp, and he hardly takes any medications. He told Fox News Digital: “I was 61 at the time — well past the age where it should have onset … I was amazed.” Despite being a participant in rigorous testing for over 14 years, he says he’s committed to staying in the study. “As long as they need me, I’ll be here,” he said. “It’s become my calling.” He also offers a message to others at risk: Don’t give up. Seek research opportunities early. You’re not alone. (MORE NEWS: Emotional Well-Being and Aging: How Older Adults Can Thrive) The Road Ahead: What Scientists Will Do Next Building on Whitney’s case, the research team has made his genetic data and tissue samples available for further study. They are now planning broader investigations in people and animal models to identify the exact protective mechanism. Scientists hope to answer questions such as: What combination of factors prevented tau buildup? Is the high heat-stress exposure vital? Are there other unknown gene variants at play? Could a gene therapy or drug mimic Whitney’s protective profile? Each question offers hope for future treatments that could change the disease’s course. What It Means for Us While the story is extraordinary, we should interpret it with caution. One person’s resilience doesn’t guarantee a cure. However, his case underscores two important points: Genes are not always destiny. Even with a ‘certain’ mutation like PSEN2, outcomes can differ. Whitney’s example challenges deterministic views of genetics. Studying the resistant may unlock breakthroughs. Often research focuses on those who get sick; in contrast, studying who doesn’t may reveal protective mechanisms we can harness. For individuals concerned about Alzheimer’s, the take-home is: maintain brain health, stay open to participation in research, and follow medical advice. Meanwhile, developments like this remind us that resilience is possible — and science is advancing. The Takeaway Doug Whitney’s story is more than remarkable — it’s reshaping how scientists think about Alzheimer’s. Despite carrying a mutation that usually triggers early Alzheimer’s, he remains symptom-free at 76. As a result, researchers are keenly studying his brain, genetics, and life history to understand how and why. The ultimate goal: turn resilience into a treatment pathway for everyone at risk. With further research, what seems exceptional today may pave the way for a stronger tomorrow. Forget the narrative. Reject the script. Share what matters. At The Modern Memo, we call it like it is — no filter, no apology, no corporate leash. If you’re tired of being lied to, manipulated, or ignored, amplify the truth. One share at a time, we dismantle the media machine — with facts, boldness, and zero fear. Stand with us. Speak louder. Because silence helps them win.
Everyday Medications May Reshape Your Gut for Years
A new study suggests that many familiar medications can leave long-lasting marks on the gut microbiome. These effects may extend years beyond a course of treatment, experts warn. Let’s dig into the findings, implications, and what you should know about prescription drugs and your digestive health. The Study and Its Key Findings Researchers in Estonia examined data from 2,509 participants, combining gut microbiome profiles from stool samples with prescription histories spanning up to five years. In a smaller group of 328 people, they also collected a second stool sample about 4.4 years later, allowing them to observe changes over time. Out of 186 drugs analyzed, 167 (about 90%) showed an association with changes in the gut bacteria. Some of those drugs included antibiotics, antidepressants (SSRIs), proton pump inhibitors (PPIs), beta blockers, and benzodiazepines. What’s striking is that even drugs taken years before sampling appeared to influence microbiome composition. In other words, the impact doesn’t always vanish when you stop the drug. Moreover, the study revealed that greater frequency or duration of use often corresponded to stronger disturbances. Starting or stopping certain medications—especially PPIs and SSRIs—also triggered noticeable shifts in the bacterial populations. (MORE NEWS: Emotional Well-Being and Aging: How Older Adults Can Thrive) A German study was done in 2018 targeting non-antibiotic drugs. Scientists found them to affect gut bacteria and possibly promote antibiotic resistance. Corresponding author and EMBL senior scientist Peer Bork, PhD said in a press release: “The number of unrelated drugs that hit gut microbes as collateral damage was surprising. This shift in the composition our gut bacteria contributes to drug side-effects, but might also be part of the drugs’ beneficial action.” Why This Matters: Gut Health and Beyond Your gut microbiome plays a critical role in digestion, immune function, and even mental well-being. Because there is strong connectivity between the gut and the brain via the vagus nerve, disruptions in gut flora can ripple outward to broader systems. Dr. Marc Siegel, Fox News senior medical analyst told Fox Digital: “You are what you eat. It may turn out that you are what medications you take, too. It can have short- and long-term implications for metabolic processes — and not only the health of the gastrointestinal system, but also the brain, because of direct links between the gut and brain via the vagus nerve. This is a study with important implications that should lead to a lot more research, especially connecting altered gut flora from various medications to various diseases.” In short, medication-induced changes in gut bacteria could influence metabolism, inflammation, and even mental health. That makes it vital to understand which drugs have the strongest associations and whether such shifts carry risks over time. Limitations and Caveats While this research is compelling, it comes with some caveats. The study only looked at prescription medications and did not include over-the-counter drugs, supplements, or herbs. People who took antibiotics or other strong medications might already have had underlying conditions that affect gut health independently. In other words, confounding factors such as disease states, diet, or lifestyle could have contributed. (MORE NEWS: YIKES! Diet Soda Gets More Bad News) Microbiome sampling was limited to stool. But gut microbes vary in different parts of the gastrointestinal tract. Thus, changes in other regions may have gone unnoticed. The completeness and accuracy of electronic health records varied. The authors acknowledged that prescription history may have gaps or misclassification. Because of these limitations, the authors called for more research—especially studies that link drug-induced microbiome changes to actual disease outcomes. Practical Takeaways for Patients and Clinicians Review necessity and duration. If a drug is essential, use the lowest effective dose and the shortest possible course. Overuse or long-term usage may magnify microbiome disruptions. Coordinate with your physician. If you’re concerned about gut health, talk with your prescriber about alternative medications or drug holidays when appropriate. Support your gut flora. Diet, probiotics, dietary fiber, and prebiotics may help rebalance microbial populations. While research is early, these lifestyle strategies often benefit gut health generally. Stay informed. This field is evolving. Ask about newer studies linking long-term medication use with gut health and related conditions. The Bottom Line This study adds to growing evidence that medications do more than just treat symptoms—they can influence the gut’s microbial ecosystem long after use. Yet, it’s too soon to draw definitive conclusions. The research suggests possibility, not proof, of long-term risks tied to drug-induced microbiome shifts. Moving forward, further longitudinal studies are essential. In the meantime, patients and clinicians should weigh benefits and risks, stay vigilant about gut health, and make medication decisions with both short-term and long-term effects in mind. Cut Through the Noise. Slice Through the Lies. Share the Truth. At The Modern Memo, we don’t tiptoe around the narrative—we swing a machete through it. The mainstream won’t say it, so we will. If you’re tired of spin, censorship, and sugar-coated headlines, help us rip the cover off stories that matter. Share this article. Wake people up. Give a voice to the truth the powerful want buried. This fight isn’t just ours—it’s yours. Join us in exposing what they won’t tell you. America needs bold truth-tellers, and that means you.
Emotional Well-Being and Aging: How Older Adults Can Thrive
Many people assume that as we age, our emotional well-being must inevitably decline. However, new research suggests otherwise, as reported by CNN. A large study of more than 8,000 older adults found that even those whose health or well-being was poor at the start were able to regain strong emotional and physical health within three years. This finding challenges the common belief that aging only brings losses. It shows that recovery and growth are possible later in life. The study, published on September 24 in the journal PLOS One, was a secondary analysis of data collected from the Canadian Longitudinal Study on Aging. “These findings apply to older adults aged 60 and over who are not currently in optimal health or well-being,” said Dr. Esme Fuller-Thomson, the study’s senior author. “The study offers hope and practical insights for older adults, caregivers, and policymakers by showing that with the right supports and lifestyle choices, many older adults can regain a high level of well-being even after experiencing sub-optimal well-being.” Researchers define optimal well-being as a balance of social support, positive attitudes toward aging, physical and mental health, life satisfaction, and independence in daily activities. The results offer hope that older adults can rebuild both emotional and physical strength, even after difficult periods. Why Emotional Well-Being Matters as Much as Physical Health Conversations about aging often focus on physical health—diet, exercise, and chronic illness. But this study shows that emotional health is just as vital for longevity and quality of life. Older adults who began the study with strong emotional well-being were nearly five times more likely to achieve overall good health after three years. This means that mindset, resilience, and emotional stability have measurable effects on how people age. (MORE NEWS: Smart Tips for Medicare Open Enrollment Success) Emotional well-being is also closely tied to lifestyle. Supportive relationships, regular exercise, quality sleep, and social activity all promote better health. Without emotional balance, even the best fitness or diet plans can lose their impact. Because many older adults face challenges such as loneliness, changing roles, and physical decline, supporting emotional resilience is key to thriving later in life. How Older Adults Can Regain Well-Being Experts point to several ways older adults can strengthen or restore their emotional health. These methods are practical and supported by science. Cultivate Strong Social Connections Social support plays a major role in emotional wellness. Staying in touch with family, friends, and community groups helps prevent loneliness and promotes a sense of purpose. Even short daily conversations can make a difference. Feeling connected to others boosts mood and motivation. Keep Moving Every Day Physical activity benefits both the body and the mind. Gentle exercise such as walking, stretching, or light strength training can improve mood, sleep, and energy levels. Even small changes—like taking the stairs or walking a few extra minutes—add up over time. Movement helps older adults maintain strength and independence. Make Sleep a Priority Good sleep is essential for emotional balance. Poor sleep can cause irritability, fatigue, and anxiety. Setting a regular bedtime, limiting caffeine, and creating a calming bedtime routine can lead to better rest and stronger emotional health. Think Positively About Aging A positive mindset can change everything. Older adults who see aging as an opportunity for learning and growth tend to feel more satisfied with life. Practicing gratitude, focusing on what’s going well, and celebrating small victories can all shift perspective and increase happiness. Avoid Harmful Habits Healthy choices protect both emotional and physical well-being. Avoiding smoking, limiting alcohol, and maintaining a balanced diet all support the body and mind. These small but consistent actions can prevent disease and improve overall mood. Find Purpose and Meaning Having a sense of purpose is one of the strongest predictors of emotional health. Engaging in hobbies, volunteering, mentoring, or creative pursuits gives life structure and meaning. Doing things that matter—no matter how small—helps older adults stay motivated and optimistic. Barriers and Important Context While the findings are hopeful, it’s important to remember that not every older adult has the same resources. Access to health care, income level, and community support can all affect recovery. People living alone or managing chronic illness may face bigger challenges. Yet the research still found that even those with serious pain or limitations were able to regain emotional and physical wellness. This shows that improvement is possible for nearly everyone. (MORE NEWS: YIKES! Diet Soda Gets More Bad News) The study also looked at patterns over time rather than testing specific treatments. It didn’t prove that one behavior alone causes recovery, but it highlighted a combination of factors that work together—emotional health, social support, and lifestyle choices. A Simple Roadmap for Emotional Renewal Older adults and caregivers can follow these practical steps to support emotional well-being: Reach out to friends and family regularly. Social connection reduces stress and boosts mood. Move your body daily. Gentle exercise keeps you strong and helps you sleep better. Create a calming bedtime routine to improve rest. Keep a gratitude journal or reflect on what went well each day. Engage in meaningful activities like volunteering, gardening, or art. Avoid smoking and limit alcohol to maintain energy and clarity. Ask for professional help if you struggle with sadness or anxiety. Counseling or group support can make a real difference. Believe that positive change is possible. Research proves that emotional recovery can happen at any age. Conclusion: Aging With Hope and Intention The main message from this research is clear: emotional well-being in later life is not fixed or destined to fade. Many older adults who started out struggling regained high levels of health and happiness within a few years. That recovery highlights the power of resilience, community, and healthy habits. Because emotional wellness can improve with effort, it’s never too late to take action. By building strong connections, staying active, maintaining a positive mindset, and finding purpose, older adults can experience renewal and joy well into their later years. Aging is not an ending—it’s an ongoing opportunity…
YIKES! Diet Soda Gets More Bad News
A major new study suggests that diet soda — often marketed as a healthier alternative to sugary sodas — may carry unexpected risks. The research shows that people who drink zero- or low-sugar artificial beverages face a higher chance of developing liver disease. Just a month ago, we wrote a news article about another study linking diet soda to faster aging — and now, this new research delivers yet another strike against them. These findings challenge what many consider to be a “safe swap.” (RELATED NEWS: Diet Soda Speeds Brain Aging, RFK Jr. Targets Additives) Study Design and Key Findings According to a press release, the study was presented at UEG Week 2025, a major European conference focused on digestive health. Researchers analyzed data from the UK Biobank, a large ongoing health study that tracks more than half a million adults in the United Kingdom. For this project, they focused on 123,788 participants who were followed for about ten years. At the beginning of the study, none of the participants had liver disease. Researchers collected detailed information on their beverage consumption, lifestyle habits, and medical history, then monitored them for signs of liver problems over the following decade. The results were striking. People who consumed sugar-sweetened beverages such as regular soda, sweetened teas, or energy drinks had about a 50 percent greater risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD), also known as nonalcoholic fatty liver disease. Even more concerning, participants who regularly drank artificially sweetened beverages — marketed as “zero sugar” or “diet” options — had an even higher risk: roughly 60 percent greater than those who rarely or never drank them. In other words, switching from sugary drinks to diet soda did not lower the risk — it may have made it worse. The researchers also found that participants who replaced either sugary or diet soda with water reduced their risk of liver disease by as much as 15 percent. However, swapping between sugary and diet drinks offered no reduction in risk. The most alarming news is the study linked frequent consumption of artificially sweetened drinks to higher rates of liver-related deaths, suggesting that the potential harm extends beyond fatty liver disease alone. Possible Mechanisms Behind the Risk Why might zero-sugar diet soda contribute to liver problems? The researchers and existing literature propose several mechanisms. Artificial sweeteners may alter the gut microbiome — the community of bacteria in the intestines. Changes there can influence metabolic functions, including how the body processes fats and sugars. (MORE NEWS: Maxwell House Rebrand: “Maxwell Apartment” Misses the Mark) These sweeteners may trigger cravings for sweets. Once the body senses something sweet, it might boost desire for sugar, potentially undermining dietary restraint. Some evidence suggests that artificial sweeteners can confuse signals of hunger and fullness, tricking the brain’s regulation systems. Although traditionally insulin reactions are associated with sugar, some studies suggest that artificial sweeteners may still provoke insulin spikes in certain individuals — a response that can contribute to metabolic stress on the liver. Strengths and Limitations This study has several strengths. First, it used a large sample size over a long period. Second, it compared both sugary and diet drinks and considered the effects of replacing them with water. However, the authors and outside observers note some important caveats: The study is observational, not experimental. It can show associations but cannot prove causation. Beverage consumption was self-reported, which may introduce measurement error or bias. People may misremember or misstate what they drank. The full paper had not yet appeared in a peer-reviewed journal, meaning some methodological details and limitations remain unknown. Despite these caveats, the associations are strong and consistent, prompting a reconsideration of how “safe” artificial sweeteners truly are. Implications for Consumers Given these findings, what should individuals do? The authors suggest caution. They argue that both sugar-sweetened and artificially sweetened diet soda should be limited. Importantly, replacing either kind of beverage with water appears safer. Water reduces metabolic burden, allows proper hydration, and avoids introducing substances that may stress the liver. In short, water remains the best choice for everyday hydration. Occasional consumption of diet or sugary beverages may not be disastrous, but relying on them heavily may carry unrecognized risk. What More Do We Need to Know? Before drawing definitive conclusions, more research is required. Specifically: Peer review and publication: The full study needs formal scrutiny and evaluation in a scientific journal. Intervention trials: Randomized controlled trials (if ethical and feasible) could help clarify cause and effect. Mechanistic studies: Work on gut microbiome changes, insulin responses, and liver metabolism can uncover how artificial sweeteners impact health. Longer follow-up: Monitoring participants for more than a decade could reveal longer-term outcomes. Diverse populations: Including people of different ages, ethnicities, and health statuses may reveal whether risks vary across groups. The Takeaway The alarming news of this study raises serious questions about the safety of diet drinks. Although many view them as healthier alternatives to sugary sodas, the evidence now suggests they may contribute to liver disease — perhaps even more than sugar itself. While causality is not proven, the strong associations, potential biological mechanisms, and comparative safety of water point toward a prudent approach: limit both sugary and diet beverages and make water your go-to. Ultimately, we need further research to confirm these findings, understand why they occur, and explore safer alternatives. In the meantime, consumers should be cautious about assuming diet drinks are harmless. Cut through the noise. Drown out the spin. Deliver the truth. At The Modern Memo, we’re not here to soften the blow — we’re here to land it. The media plays defense for the powerful. We don’t. If you’re done with censorship, half-truths, and gaslighting headlines, pass this on. Expose the stories they bury. This isn’t just news — it’s a fight for reality. And it doesn’t work without you.
Autism Hope Grows With Promising Developments
Big news is swirling around autism research, and it has parents, doctors, and advocates paying attention. For years, families have asked why autism rates keep climbing and what can be done to help children thrive. Now, two new developments may offer clues and hope. While these findings remain preliminary, they carry real promise. The Possible Link Between Tylenol and Autism President Donald Trump and U.S. health officials point to studies that suggest a possible connection between acetaminophen (best known as Tylenol) use during pregnancy and a higher risk of autism in children. They allege that expectant mothers who take large amounts of acetaminophen may unknowingly increase the odds of autism or ADHD in their children. God bless you, President Trump, for being brave. pic.twitter.com/E9Hweu8d2Y — Secretary Kennedy (@SecKennedy) September 22, 2025 This theory is based on several long-running studies, including the Boston Birth Cohort and the Nurses’ Health Study. Researchers reported patterns that seem to connect prenatal acetaminophen use with later developmental challenges. Officials like FDA Commissioner Marty Makary say the data are “too strong to ignore.” Of course, not everyone agrees. Tylenol’s manufacturer, Kenvue, disputes the claims, saying sound science does not prove a causal link. Tylenol made a statement on its website: Many independent doctors also warn that much more research is needed before conclusions are drawn. Still, the fact that this conversation is now on the national stage could mark a turning point. It signals that researchers may finally be on to something about one of the many possible contributors to autism. (MORE NEWS: Gen Z Credit Scores Drop, But Future Looks Bright) Trump Raises Concerns on Childhood Vaccinations President Trump also brought to light another issue he believes deserves national attention: childhood vaccinations. Trump warned against over-vaccinating babies and young children, saying, “It’s too much liquid, too many different things are going into that baby at too big a number the size of this thing. When you look at it, it’s like 80 different vaccines and beyond vaccines, 80, and you give that to a little kid.” Secretary Robert F. Kennedy Jr. echoed those concerns, emphasizing that families deserve to be heard. “Some 40-70% of mothers who have children with autism believe that their child was injured by a vaccine. President Trump believes that we should be listening to these mothers instead of gaslighting and marginalizing them like prior administrations.” “Some 40-70% of mothers who have children with autism believe that their child was injured by a vaccine. President Trump believes that we should be listening to these mothers instead of gaslighting and marginalizing them like prior administrations.” – @SecKennedy pic.twitter.com/491tqIpgKy — The White House (@WhiteHouse) September 23, 2025 The comments highlight a larger debate about medical freedom, parental choice, and how government agencies handle vaccine schedules for children. Both Trump and Kennedy framed the issue as one of respect for parents and accountability from institutions that have too often dismissed their voices. A Cancer Drug May Offer New Hope The second development is even more uplifting for families already living with autism. A cancer drug called leucovorin, long used for anemia and chemotherapy support, is now being tested for new purposes. Early studies show that leucovorin may help non-verbal children with autism begin to speak, improve social skills, pay attention longer, and reduce repetitive behaviors. Doctors who have studied leucovorin in this new context are calling the results encouraging. Imagine a child who has never spoken a word suddenly beginning to form sentences after treatment. Parents in early studies have reported exactly that. To be clear, leucovorin is not yet approved by the FDA for autism treatment. Right now, doctors can only prescribe it “off-label.” But regulators are already reviewing evidence and have hinted they may update the drug label to reflect potential use in speech-related deficits tied to autism. That would be a major step forward. The Autism Action Plan: A Three-Part Strategy The White House also laid out a structured Autism Action Plan that signals a serious national commitment. The plan focuses on three major steps. Informing Doctors and Families The FDA will issue a physician notice and update safety labels on acetaminophen, citing a potential association between prenatal use and adverse neurodevelopmental outcomes. The Department of Health and Human Services will also launch a nationwide campaign to educate families and protect public health. Making a Therapeutic Available The FDA will recognize leucovorin as the first therapeutic for children with cerebral folate deficiency and autistic symptoms. Once approved, state Medicaid programs will be able to cover leucovorin for autism spectrum disorder. At the same time, the National Institutes of Health will conduct confirmatory trials to better understand its impact. Increasing Research Investment Through the Autism Data Science Initiative, the NIH will invest more than $50 million to fund 13 new projects. These efforts are designed to push forward understanding, therapies, and long-term solutions for autism. Rep. Mary Miller weighs in on this bold plan: For decades, politicians ignored the rise of autism in America. President Trump is taking action. His Autism Action Plan will inform parents, expand treatment, and fund research, finally delivering answers families have needed for years. This is the leadership we prayed for! pic.twitter.com/qAMxd2xTDM — Rep. Mary Miller (@RepMaryMiller) September 22, 2025 Why Families Should Pay Attention This is where the story gets exciting. Autism affects about one in 31 eight-year-olds, according to the CDC. That’s a big jump compared to past decades. Parents, teachers, and doctors have worked tirelessly to adapt, but the need for answers is growing. With support now coming directly from the Trump administration, there is new momentum to get to the bottom of things. That support could move the needle forward on both research and practical help for families. For years, much of the focus has been on behavioral therapies and classroom strategies. Those tools help, but they don’t address the underlying biology. Now, with possible environmental links like acetaminophen and vaccines and potential medical treatments like leucovorin, science may finally be uncovering deeper…
Diet Soda Speeds Brain Aging, RFK Jr. Targets Additives
A new study published in the journal Neurology suggests that drinking diet soda every day may speed up brain aging. Researchers followed 12,772 adults in Brazil for eight years. They found that people who consumed the most artificial sweeteners had a much faster decline in memory and thinking skills. The results were striking. Heavy users showed a 62 percent faster decline. That decline equaled about 1.6 extra years of brain aging. The study looked at several popular sweeteners. These included aspartame, saccharin, acesulfame-K, erythritol, xylitol, and sorbitol. Tagatose was the only one that did not show harm. All the others were linked to measurable cognitive decline. New Study Published in @GreenJournal: Some sugar substitutes linked to faster cognitive decline. https://t.co/XcZJVtIGHC#AANscience #BrainHealth pic.twitter.com/FWCdtJg0es — American Academy of Neurology (@AANmember) September 4, 2025 Midlife Habits Matter The findings showed the strongest impact in adults under 60. People with diabetes were also more vulnerable. Older adults over 60 showed no major difference, but the researchers warned that habits in midlife set the stage for brain health later on. Cognitive decline often begins decades before symptoms appear. A loss of 1.6 years of brain function may not sound dramatic, but across a population it is significant. This makes diet choices in middle age especially important. People often believe switching to diet soda protects their health. The research shows the story may be more complicated. Artificial sweeteners may reduce sugar intake, but they could come with hidden risks. (RELATED NEWS: SNAP Soda Ban: Ending Taxpayer Junk Food Subsidies) What the Experts Say Claudia Kimie Suemoto, the study author and a neurologist at the University of São Paulo, explained that people often see artificial sweeteners as harmless. She said the results suggest they may not be harmless, especially with frequent use in midlife: “Low- and no-calorie sweeteners are often seen as a healthy alternative to sugar, however our findings suggest certain sweeteners may have negative effects on brain health over time,” Other physicians note that reducing sugar can still help some people. But they also encourage natural alternatives when possible. Not everyone agrees on the interpretation. Industry groups argue that these sweeteners remain safe. They point out that all of the common sweeteners studied are approved by the Food and Drug Administration. The Trump Administration’s Warning However, the Trump Administration’s “Make Our Children Healthy Again” Assessment, released in May 2025 by the Make America Healthy Again Commission, directly addressed these additives. The commission, chaired by HHS Secretary Robert F. Kennedy, Jr., stated: “Artificial sweeteners like aspartame, sucralose, and saccharin, used widely in diet sodas and sugar-free foods, have been observed to interfere with the gut microbiome in some studies. Gut microbiome shifts have been linked to obesity, metabolic issues, and possibly glucose intolerance. The classification of aspartame as possibly carcinogenic (Group 2B) by the International Agency for Research on Cancer (IARC) further complicates the understanding of these widely used substances, especially given the existence of conflicting research results.” Kennedy has made it clear that he is on a mission to bring these risks to light. His push is not just about raising awareness but about eliminating harmful additives from the American diet altogether. By targeting products that undermine metabolic and brain health, RFK Jr. has positioned this fight as central to protecting the next generation. Why This Matters The debate highlights a bigger question. What is the real cost of relying on artificial substitutes? Diet sodas and low-calorie snacks are everywhere. People turn to them to manage weight or blood sugar. Yet brain health may be part of the tradeoff. Studies like this raise awareness about long-term risks. They also remind us that brain aging is not just a concern for seniors. For people in their 40s and 50s, the choices made today may shape how sharp the mind feels at 70 or 80. The study adds to a growing body of evidence that diet and lifestyle strongly affect the brain. What You Can Do Experts recommend moderation above all. Cutting back on artificial sweeteners can lower risk. Reading labels helps, since many “monk fruit” or “stevia” products are mixed with other sweeteners like erythritol. Choosing whole foods, fruits, and naturally sweetened items offers a safer path. Exercise also plays a key role. Physical activity helps the brain produce protective proteins and supports memory. Good, healthy habits form a stronger shield for long-term health. (RELATED NEWS: Tracy Beanz Reveals MAHA’s Mission & What Comes Next In Fascinating Interview) The Bigger Picture Artificial sweeteners have already faced criticism. Some past research connected them to gut health problems and metabolic changes. Others raised questions about possible links to strokes or heart issues. While the science is not settled, the pattern is clear. When used in excess, these substitutes may not deliver the safe solution people expect. None of this means sugar is healthy. High sugar intake is a proven risk factor for diabetes, obesity, and heart disease. The challenge is replacing sugar. That leaves many people searching for better alternatives. Small amounts of honey, maple syrup, or fruit can satisfy a sweet craving without the same risks. A Wake-Up Call for Consumers The study’s authors stressed that their results show association, not cause. Still, the message is clear enough for everyday life. If you drink diet soda daily, it may be time to cut back. Brain health is precious, and the habits you build now may protect you later. This is not a call to panic. It is a reminder to stay alert and informed. Labels and marketing often sell artificial sweeteners as a free pass. Science now suggests the pass may come with hidden costs. The best steps are simple. Limit sweeteners, eat healthy foods, and stay active. Your brain depends on it. Cut through the noise. Drown out the spin. Deliver the truth. At The Modern Memo, we’re not here to soften the blow — we’re here to land it. The media plays defense for the powerful. We don’t. If you’re done with censorship, half-truths, and…
AI Stethoscope Spots Deadly Heart Conditions 15 Seconds
A Breakthrough in Heart Care Researchers at Imperial College London developed an AI-enabled stethoscope, according to Fox News. It detects three serious heart conditions in just 15 seconds. These include heart failure, atrial fibrillation, and heart valve disease. The results emerged from a large trial involving over 12,000 symptomatic patients across many GP practices. A smart stethoscope powered by AI can detect heart failure, atrial fibrillation or valve disease in just 15 seconds 🩺@ImperialMed’s Dr Patrik Bächtiger says it’s “incredible” how quickly AI could deliver results from a simple exam. Read more ⬇️https://t.co/dLlfvKrZx0 pic.twitter.com/EMoCEOjZws — Imperial College London (@imperialcollege) September 3, 2025 How the AI Device Works The device is compact—about the size of a playing card. It records both heart sounds and electrical signals. Then it sends the data to the cloud. Artificial Intelligence analyzes the information. Within seconds, results appear on a smartphone. Doctors gain instant insights into potential heart problems. (MORE TECH NEWS: Pregnancy Robots: Miracle or Ethical Nightmare?) Strong Trial Findings in General Practice Patients tested with the AI stethoscope were twice as likely to receive a heart failure diagnosis. They were 3.5 times more likely to be diagnosed with atrial fibrillation. They were nearly twice as likely to receive a heart valve disease diagnosis. These rates far exceeded those from traditional stethoscopes. Early Detection Saves Lives Early diagnosis can save lives. Many patients learn they have heart disease only after arriving in emergency care. By then, treatment options shrink. Quick detection enables earlier intervention. It can reduce hospital stays and improve long-term health outcomes. AI Limits and Concerns The technology is not foolproof. Around two thirds of patients flagged for potential heart failure later tested negative. False positives can cause anxiety and lead to extra testing. Researchers emphasize that AI stethoscopes suit only symptomatic cases—not routine screening in healthy individuals. Challenges for AI in Clinical Use Adoption remains a hurdle. Around 70% of clinicians who initially used the device stopped within a year. Many cited difficulty integrating it into daily practice. Streamlined design and seamless workflow fit are crucial for broader uptake. Real-World Reach: Pregnancy Care Insights A separate study conducted by the Mayo Clinic showed that an AI-enabled digital stethoscope helped detect twice as many cases of pregnancy-related heart failure compared to usual care. This trial took place in Nigeria. It found that AI-assisted screening was also 12 times more likely to detect severe heart pump weakness, known as peripartum cardiomyopathy. Pregnant women often experience symptoms like shortness of breath, fatigue, and swelling. These can mimic normal pregnancy signs. Yet early detection is vital for treatment and for protecting mothers’ lives. Demilade Adedinsewo, M.D., cardiologist at Mayo Clinic and lead investigator of the study said: “Recognizing this type of heart failure early is important to the mother’s health and well-being. The symptoms of peripartum cardiomyopathy can get progressively worse as pregnancy advances, or more commonly following childbirth, and can endanger the mother’s life if her heart becomes too weak. Medicines can help when the condition is identified but severe cases may require intensive care, a mechanical heart pump, or sometimes a heart transplant, if not controlled with medical therapy.” AI-enabled stethoscopes can close diagnostic gaps. Dr. Adedinsewo emphasized how mothers lack a simple, non-invasive, safe screening test. Artificial Intelligence tools could improve access to early heart detection. They could help obstetric providers refer patients faster to specialists. New 🗞️ 🚨! @AnnFamMed: AI tools show promise in detecting cardiac dysfunction among young women as part of preconception cardiovascular care! #AI #CardioObstetrics #WomensHealth @MayoClinicCV https://t.co/evBM3HbGKU pic.twitter.com/PvwKkzeuSK — Demi Adedinsewo, MD (@DemiladeMD) April 29, 2025 Looking Ahead Expansion plans are underway. Regions like South London, Sussex, and Wales may soon incorporate the AI tool in community clinics. Broader use could democratize advanced diagnostics across primary care settings. Meanwhile, Mayo Clinic’s work highlights how Artificial Intelligence can transform obstetric heart screening. With more validation and ease of use, the tool could become a game-changer in maternal health. Balancing Promise with Caution In an interview with Fox News, Cardiothoracic surgeon Dr. Jeremy London said: “The AI stethoscope should be used for patients with symptoms of suspected heart problems, and not for routine checks in healthy people. AI is a framework, not as an absolute, because it can be wrong. Particularly when we’re taking care of people … we must make certain that we are doing it properly.” The AI stethoscope upgrades a centuries-old tool. It produces faster and more objective heart assessments. It supports early diagnosis and may reduce heart-related deaths. Yet care remains key. Misfiring alarms and integration issues must be addressed. Artificial Intelligence should augment—not replace—human care. In Conclusion The AI stethoscope offers exciting possibilities for heart health. It speeds diagnosis. It strengthens early detection—especially in vulnerable patients like pregnant women. When used wisely, it can change primary care and improve patient outcomes. With thoughtful rollout and clinical backup, it may save lives and transform heart care. Beyond this single tool, the potential of AI in medicine is immense. As algorithms grow more accurate and devices become easier to use, AI can serve as a powerful diagnostic partner across specialties. It can detect disease earlier, support overworked physicians, and expand access to quality care in underserved areas. From stethoscopes to imaging, from lab work to personalized treatment plans, Artificial Intelligence is reshaping the front lines of medicine. The future promises a healthcare system where doctors and Artificial Intelligence work side by side—human expertise enhanced by machine precision. This partnership could deliver faster answers, better outcomes, and healthier lives for millions around the world. Forget the Headlines. Challenge the Script. Deliver the Truth. At The Modern Memo, we don’t tiptoe through talking points — we swing a machete through the media’s favorite lies. They protect power. We confront it. If you’re sick of censorship, narrative control, and being told what to think — stand with us. Share the story. Wake the people. Because truth dies in silence — and you weren’t made to stay quiet.
EXCLUSIVE: 20,000,000 Sick Americans Abandoned By Medical ‘Oligarchy’ Controlled By Elites; Can We Fix It?
Opinions expressed are solely those of the author(s). In former President Biden’s January 2025 farewell speech, he warned of the risk of the U.S. becoming an oligarchy, a government controlled by a select group of ultra-wealthy and elite individuals. While Biden was referring to the government, my over two-decade career in healthcare has led me to see a similar dynamic in science and medicine. For years, this elite group’s dominance went unchallenged, accepted by both the medical community and the public, perhaps out of naivety or complacency. However, the COVID-19 pandemic pulled back the curtain, offering the public a rare glimpse into how medical policies and decisions are made, revealing the sway of these elites. Rise of Medical Censorship Debates over treatments, vaccine development, vaccine mandates, and public health strategies like lockdowns and school closures showcased the power dynamics at play. Over time, as some of these decisions were questioned or refuted, there emerged a demand for accountability and a questioning of expertise, with some moves seen as missteps or swayed by external pressures rather than scientific merit alone. Adding fuel to the fire, these elites mocked and insulted anyone, including their peers and colleagues, while calling for censorship of those questioning their dominance and views. Who are these elites, and what role do they play in medicine? They are highly educated individuals from prestigious institutions whose influence shapes both public opinion and medical practice through their research and academic roles. Their control is solidified by publications in high-impact journals, which set the standards for medicine. In federal health agencies like the NIH, FDA, or CDC, they wield significant power over policy, treatment approval, and research funding. Through books, media, and platforms like TED talks, they also mold public perception and policy, often setting the health agenda. Their decisions can skew healthcare towards specific philosophies or interests. The dominance of these elites rests on three pillars: control of information, gatekeeping opportunities, and influencing policy and practice. They manage information flow through the peer-review system, where high-impact journals act as gatekeepers, often favoring insiders. This control shapes medical education and practice. Their prestigious roles and platforms grant them access to funding and career opportunities, making it tough for outsiders to challenge or innovate within established narratives. Questioning their orthodoxies and dominance will often lead them to publicly insult you, question your credentials and training, and send journalists looking for a story and a social media mob after you. Silencing The Truth On COVID-19 and the Vaccines My collaboration with Dr. Bruce Patterson on long COVID research over the last four years has shown similar patterns. Long COVID, a condition defined as new onset symptoms persisting beyond three months post-SARS-CoV-2 infection, is affecting over 20 million Americans and 65 million people worldwide. The research focus, funding, and narrative around long COVID are heavily shaped by these same academics and medical elites, influencing which symptoms are addressed, treatments pursued, and patient management strategies adopted. There is a risk that novel insights or treatments might struggle for acceptance unless they align with the views of these influential figures. This dynamic is starkly illustrated by the NIH RECOVER COVID initiative, a $1.6 billion US taxpayer-funded effort on long COVID that has been criticized for its shortcomings. A report in STATNEWS highlighted a lack of transparency in funding criteria and dispersal; criticized the glacial pace of research; and noted the failure to set up well-designed clinical trials to study various therapeutics. Research on symptoms and patient surveys has minimal clinical utility in 2025 when millions of people continue to suffer and enough published research points to vascular inflammation driving the underlying pathology. Competition Over Collaboration I have observed more competition rather than collaboration among long COVID research groups. The divisive politicization of our country has falsely and cruelly framed long COVID as a quasi-liberal female psychiatric disorder. Likewise, those people suffering from post-COVID-19 vaccine syndrome, a condition similar to long COVID, have been ignored, smeared, and abused as “anti-vaxxers.” With the newly confirmed Robert F. Kennedy as Secretary of Health and Human Services and the nomination of Dr. Jay Bhattacharya at the helm of the NIH, there exists a tremendous opportunity for both leaders to shape the long COVID narrative by shifting towards an inclusive and transparent policy-making process and fostering environments for collaborative rather than competitive research. Besides fostering collaboration and transparency in research funding, well-designed clinical trials on FDA approval pathways are desperately needed for the millions of disabled and suffering patients. By addressing these areas, there’s a chance to mitigate the oligarchic tendencies within medical science, increase accountability, and better serve the health needs of the population, particularly those with conditions like long COVID. Ram Yogendra M.D., M.P.H. is a board-certified anesthesiologist with a diverse background in medicine and public health. He has experience in infection control and surveillance from prior public health roles before shifting to clinical practice. Dr. Yogendra now contributes to research on Long COVID and post-COVID vaccine syndrome, co-authoring several studies on immune responses and treatments. Follow him on X @dryostradamus Read Dr. Ram Yogendra’s articles here: Long COVID diagnostic with differentiation from chronic lyme disease using machine learning and cytokine hubs – Nature Case series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC) – Frontiers Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning – Frontiers Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection – Frontiers Get News. Take Action. The Modern Memo was not designed to be your go-to site for breaking news; we’re better than that. You’re reading this post because you care more about America’s future than simply reposting rage-inducing headlines. You are the kind of patriot who wants to take action with your new knowledge; this is where we come in. Like you, we’re absolutely sick and tired of not being able to shape policy or protect American families outside of election…